Tirzepatide or Mounjaro has started being recognized as a remarkable weight loss injection across the globe the United Kingdom included It is not only made for achieving weight loss goals but it is al ...

A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...

Momentum investing is based on the idea that stocks that have risen recently will tend to keep rising and that stocks that ...

Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Monday. The company is set to join to the S&P SmallCap 600 this ...

Tirzepatide injection (Zepbound, Mounjaro) is officially off the FDA's drug shortage list, meaning compounders can no longer prepare and dispense the drug.

Turkey's Huzur Devletsah is the first woman to head Eli Lilly's China affiliate since the U.S. pharma maker began operations ...

We recently compiled a list of the 8 Best Momentum Stocks To Invest In Right Now. In this article, we are going to take a ...

Drug and biotech companies are seeing significant innovation in 2024. In the Large-Cap Pharmaceuticals industry, Eli Lilly ...

GLP-1 drugs are being recommended on social media, raising questions about who can see the content and what the effects might ...

Regeneron, a leading biotech firm, is testing a drug called trevogrumab to preserve lean muscle while using these medications ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 584.52% and ...

The regimen began with a prescription for tirzepatide, found in the trendy medications Mounjaro and Zepbound, approved by the FDA for Type 2 diabetes and weight loss, respectively. Besides taking the ...